Suppr超能文献

全合成自组装肽溶液作为黏膜下注射材料的可行性:初步动物研究。

The feasibility of a fully synthetic and self-assembled peptide solution as submucosal injection material: a preliminary animal study.

机构信息

Department of Gastroenterology and Hepatology, Gunma University Graduate School of Medicine, Maebashi, Japan.

Gastroenterology and Endoscopy Unit, Pavillon L, Edouard Herriot Hospital, Lyon, France.

出版信息

Scand J Gastroenterol. 2021 Aug;56(8):984-989. doi: 10.1080/00365521.2021.1934727. Epub 2021 Jun 28.

Abstract

BACKGROUND AND AIM

An injection solution is required to create a submucosal cushion (SMC) for safe endoscopic resection procedures. The aim of this preliminary animal study was to clarify the safety and efficacy of a novel fully synthetic and self-assembled peptide (FSSP) solution as a submucosal injection material (SMIM).

METHOD

To compare the submucosal-lifting properties, 0.3% FSSP, Eleview, sodium hyaluronate acid solution (SHA) and normal saline (NS) were randomly injected using an injection needle into the submucosa of exposed stomach and colon in five living dogs in a blind fashion. The mean height, and volume of SMCs were measured using a digital caliper immediately and 10, 20, 30, and 40 min after injecting each solution. All resected specimens were examined histopathologically.

RESULTS

In both the colon and stomach, ANOVA for repeated measures showed the significant interaction between time and solution for the time-dependent change in the height. In the colon, FSSP created significantly higher SMC than NS 20 min after injection ( = .0015) and Eleview and NS 40 min after injection ( = .0009 and  = .0002). Furthermore, FSSP and SHA tended to maintain height and volume when compared to the other two solutions. In the stomach, FSSP and SHA tended to maintain height and volume when compared to the other two solutions. There were no significant differences between the histopathological finding and the injecting solutions used.

CONCLUSION

FSSP seems to be useful as a SMIM for endoscopic resection especially in the colon. Further studies are needed prior to clinical use of FSSP.

摘要

背景与目的

黏膜下注射溶液是内镜下安全切除操作的必需条件。本初步动物研究旨在明确一种新型全合成自组装肽(FSSP)溶液作为黏膜下注射材料(SMIM)的安全性和有效性。

方法

为了比较黏膜下抬举性能,我们以盲法将 0.3% FSSP、Eleview、透明质酸钠溶液(SHA)和生理盐水(NS)分别用注射针随机注入暴露的胃和结肠黏膜下。使用数字卡尺立即以及注射后 10、20、30 和 40 分钟测量 SMC 的平均高度和体积。所有切除标本均行组织病理学检查。

结果

在结肠和胃中,重复测量方差分析显示,高度的时间依赖性变化与溶液之间存在显著的交互作用。在结肠中,FSSP 在注射后 20 分钟时比 NS ( = .0015)和 Eleview 和 NS ( = .0009 和  = .0002)产生的 SMC 更高。此外,与其他两种溶液相比,FSSP 和 SHA 倾向于维持高度和体积。在胃中,与其他两种溶液相比,FSSP 和 SHA 倾向于维持高度和体积。组织病理学发现与所用注射溶液之间无显著差异。

结论

FSSP 似乎可作为内镜切除的有用 SMIM,尤其在结肠中。在临床应用 FSSP 之前需要进一步研究。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验